160 related articles for article (PubMed ID: 29074257)
1. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
[TBL] [Abstract][Full Text] [Related]
2. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Moon R; Mawet J; Ertel EA; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5322-5325. PubMed ID: 29066309
[TBL] [Abstract][Full Text] [Related]
3. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
[TBL] [Abstract][Full Text] [Related]
4. Lead discovery and optimization of T-type calcium channel blockers.
Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.
Renneberg D; Hubler F; Rey M; Hess P; Delahaye S; Gatfield J; Iglarz M; Hilpert K
Bioorg Med Chem Lett; 2015 Sep; 25(18):3941-6. PubMed ID: 26231163
[TBL] [Abstract][Full Text] [Related]
6. Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide.
El-Wakil MH; Teleb M; Abu-Serie MM; Huang S; Zamponi GW; Fahmy H
Bioorg Chem; 2021 Oct; 115():105262. PubMed ID: 34411980
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and pharmacological evaluation of some substituted dihydropyrimidines with L-/T-type calcium channel blocking activities.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Mar; 83():354-366. PubMed ID: 30408648
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers.
Kim HS; Kim Y; Doddareddy MR; Seo SH; Rhim H; Tae J; Pae AN; Choo H; Cho YS
Bioorg Med Chem Lett; 2007 Jan; 17(2):476-81. PubMed ID: 17092715
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
Shipe WD; Barrow JC; Yang ZQ; Lindsley CW; Yang FV; Schlegel KA; Shu Y; Rittle KE; Bock MG; Hartman GD; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Uebele VN; Nuss CE; Connolly TM; Doran SM; Fox SV; Kraus RL; Marino MJ; Graufelds VK; Vargas HM; Bunting PB; Hasbun-Manning M; Evans RM; Koblan KS; Renger JJ
J Med Chem; 2008 Jul; 51(13):3692-5. PubMed ID: 18540666
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.
Yang HK; Son WS; Lim KS; Kim GH; Lim EJ; Gadhe CG; Lee JY; Jeong KS; Lim SM; Pae AN
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1460-1471. PubMed ID: 30231778
[TBL] [Abstract][Full Text] [Related]
12. Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 1: synthesis and inhibitory activity of 5-(1-methyl-3-trifluoromethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamides.
Yonetoku Y; Kubota H; Okamoto Y; Toyoshima A; Funatsu M; Ishikawa J; Takeuchi M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2006 Jul; 14(14):4750-60. PubMed ID: 16580212
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR study of T-type calcium channel blockers. Part II.
Choe YJ; Seo HN; Jung SY; Rhim H; Kim J; Choo DJ; Lee JY
Arch Pharm (Weinheim); 2008 Oct; 341(10):661-4. PubMed ID: 18816587
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
[TBL] [Abstract][Full Text] [Related]
15. Pyridyl amides as potent inhibitors of T-type calcium channels.
Reger TS; Yang ZQ; Schlegel KA; Shu Y; Mattern C; Cube R; Rittle KE; McGaughey GB; Hartman GD; Tang C; Ballard J; Kuo Y; Prueksaritanont T; Nuss CE; Doran SM; Fox SV; Garson SL; Li Y; Kraus RL; Uebele VN; Renger JJ; Barrow JC
Bioorg Med Chem Lett; 2011 Mar; 21(6):1692-6. PubMed ID: 21316226
[TBL] [Abstract][Full Text] [Related]
16. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor.
Giordanetto F; Wållberg A; Knerr L; Selmi N; Ullah V; Thorstensson F; Lindelöf Å; Karlsson S; Nikitidis G; Llinas A; Wang QD; Lindqvist A; Högberg G; Lindhardt E; Åstrand A; Duker G
Bioorg Med Chem Lett; 2013 Jan; 23(1):119-24. PubMed ID: 23200256
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channels.
Sairaman A; Cardoso FC; Bispat A; Lewis RJ; Duggan PJ; Tuck KL
Bioorg Med Chem; 2018 Jul; 26(11):3046-3059. PubMed ID: 29622412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
